AKT1 and non-small cell lung carcinoma: It has been shown that down-regulation of VEGF decreases ERK1/2 and AKT activation in NSCLC, leading to pronounced inhibition of tumor growth, angiogenesis, invasion/migration, and promotion of cell death (apoptotic or autophagic)[59].